Fluconazole Dosing for a 16.33 kg Child
For a child weighing 16.33 kg, administer fluconazole 40 mg/mL suspension based on the specific indication: for oropharyngeal candidiasis, give a loading dose of 98 mg (2.5 mL) on day 1, followed by 49 mg (1.2 mL) once daily; for esophageal candidiasis, give 98 mg (2.5 mL) on day 1, followed by 49 mg (1.2 mL) once daily, with doses up to 196 mg (4.9 mL) daily if needed; for invasive candidiasis, give 98-196 mg (2.5-4.9 mL) twice daily.
Dosing by Indication
Oropharyngeal Candidiasis
- Loading dose (Day 1): 6 mg/kg = 98 mg = 2.5 mL of 40 mg/mL suspension
- Maintenance dose (Day 2 onward): 3 mg/kg = 49 mg = 1.2 mL once daily
- Duration: Minimum 2 weeks 1
The FDA label and CDC/NIH guidelines consistently recommend this loading dose approach for oropharyngeal disease 2, 1. The 6 mg/kg loading dose followed by 3 mg/kg maintenance is the standard of care with strong evidence (AI rating) 2.
Esophageal Candidiasis
- Loading dose (Day 1): 6 mg/kg = 98 mg = 2.5 mL
- Maintenance dose (Day 2 onward): 3-6 mg/kg = 49-98 mg = 1.2-2.5 mL once daily
- Maximum if needed: Up to 12 mg/kg = 196 mg = 4.9 mL daily based on clinical response 1
- Duration: Minimum 3 weeks AND at least 2 weeks after symptom resolution 2, 1
The guidelines emphasize that esophageal disease requires higher doses than oropharyngeal disease, with the option to escalate to 12 mg/kg daily for refractory cases 2.
Invasive Candidiasis (Candidemia, Disseminated Disease)
- Dosing: 5-6 mg/kg twice daily = 82-98 mg twice daily = 2.0-2.5 mL twice daily
- Total daily dose: 164-196 mg (maximum 600 mg/day per guidelines)
- Duration: Minimum 4 weeks if uncomplicated C. albicans candidemia 2
For invasive disease, the twice-daily dosing is critical to achieve adequate drug exposure. The CDC/NIH guidelines specify 5-6 mg/kg IV or orally twice daily with AI-level evidence 2.
Important Clinical Considerations
Loading Dose Rationale
A loading dose achieves therapeutic concentrations more rapidly. Research demonstrates that a 25 mg/kg loading dose in infants achieved therapeutic targets (AUC >400 mg·h/L) in 63% of patients on day 1, compared to delayed achievement with standard dosing 3. While this study used 25 mg/kg in infants, the FDA-approved 6 mg/kg loading dose for children is the standard recommendation 1.
Therapeutic Drug Monitoring
For invasive disease, consider therapeutic drug monitoring if available. Target trough concentrations are >2 μg/mL for prophylaxis and >8 μg/mL for treatment of invasive disease 4. The therapeutic target AUC is >400 mg·h/L for candidemia 3, 4.
Renal Function
Critical caveat: If serum creatinine is elevated (>1.3 mg/dL in children), fluconazole clearance is significantly reduced 4, 5. In this scenario:
- Administer the full loading dose
- Reduce maintenance dose by 50% if creatinine clearance <50 mL/min 1
- Monitor creatinine; if it remains elevated >96 hours, dose adjustment is mandatory 4
Species-Specific Considerations
Do not use fluconazole empirically for fungemia without speciation because C. krusei is intrinsically resistant and C. glabrata often demonstrates reduced susceptibility 2. If these species are suspected or confirmed, switch to an echinocandin or amphotericin B 2, 6.
Administration
Fluconazole can be taken with or without food 1. The oral suspension has excellent bioavailability (>90%), making it equivalent to IV administration for patients who can tolerate oral intake 1.
Common Pitfalls to Avoid
- Underdosing invasive disease: Using once-daily dosing for candidemia instead of twice-daily dosing results in subtherapeutic exposure
- Premature discontinuation: Stopping therapy when blood cultures clear rather than continuing for the full 2-4 weeks increases relapse risk 2, 6
- Ignoring renal function: Failure to adjust for renal impairment leads to drug accumulation and toxicity 1, 4
- Using fluconazole for non-albicans species: Empiric use without knowing susceptibility patterns risks treatment failure 2